The Danish Medicines Agency and the Danish Medicine Verification Organisation (DMVO) work closely together to ensure an effective and safe implementation of the EU’s Falsified Medicines Directive (FMD) in Denmark. Our common goal is to protect patients, prevent falsified medicines in the supply chain and maintain the high level of trust in the pharmaceutical supply chain in Denmark. This collaboration is crucial to ensure that all actors – from manufacturers to pharmacies – have a well-functioning system that supports traceability and safety.

DMVO as a partner in the administration of FMD offers a number of services that support the work of the authorities, and especially the Danish Medicines Agency. These include:

Dialogue and support for questions about the Danish Medicine Verification System (DMVS)
We are available for dialogue and technical clarification, so that the authorities always have the necessary knowledge to make decisions.

Regular updates on system status and development
The authorities are kept regularly informed about changes in the system, new features and relevant updates from EMVO and the EU.

Possibility of tailor-made reports for regulatory needs
DMVS offers reports that have been developed in collaboration with the European Medicines Agencies (NCAs) to match the regulatory requirements or analysis needs of the authorities, providing targeted and effective insights.

We believe that close collaboration between DMVO and authorities is key to maintaining a robust and secure system that protects patients and strengthens trust in the pharmaceutical supply